“The FDA’s internal AI tool, Elsa … can assist with synthesizing and summarizing information, refining communication, outlining content, drafting, proofreading, and basic coding tasks,” the FDA told Fortune in a statement, adding that Elsa is used to help with administrative and daily activities.
Fantasy author Sarah J. Maas has big plans for the future of A Court of Thorns and Roses. In an appearance on the March 4 episode of the Call Her Daddy podcast, Maas revealed that not one but two new ACOTAR books are on the way — and they'll be arriving just a few months apart.
。快连官网对此有专业解读
此次基石投资者合计获配2012.01万股，占全球发售49.21%，所认购股份的锁定期截至2026年8月2日。
Facebook accounts unavailable in worldwide outage